Pulmonx Corp (LUNG)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Pulmonx Corp-Aktie (LUNG)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-06-30	2024-03-31	2023-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.86% 23.86	22.54	20.78	18.85	19.28
Cost Of Revenue	7.41% 6.655	6.196	5.476	4.776	4.878
Gross Profit	5.27% 17.20	16.34	15.31	14.08	14.40
Operating Expenses	3.57% 32.01	30.91	30.93	28.61	28.32
Benefits Costs and Expenses	5.44% 38.85	36.85	36.02	32.42	32.92
Costs And Expenses	5.44% 38.85	36.85	36.02	32.42	32.92
Operating Income/Loss	1.65% -14.80	-14.56	-15.62	-14.54	-13.92
Income/Loss From Continuing Operations Before Tax	4.77% -15.00	-14.31	-15.24	-13.56	-13.64
Income Tax Expense/Benefit	31.11% 0.177	0.135	0.084	0.186	0.248
Income/Loss From Continuing Operations After Tax	5.02% -15.17	-14.45	-15.33	-13.75	-13.89
Net Income/Loss	5.02% -15.17	-14.45	-15.33	-13.75	-13.89
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.19% 40.43	39.95	38.94	38.64	0.1357
Diluted Average Shares	1.19% 40.43	39.95	38.94	38.64	0.1357
Basic Earnings Per Share	5.56% -0.38	-0.36	-0.39	-0.36	-0.36
Diluted Earnings Per Share	5.56% -0.38	-0.36	-0.39	-0.36	-0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

STE

$245.30

0.78%

PODD

$348.43

0.57%

PHG

$27.93

0.72%

DXCM

$80.51

0.31%

GEHC

$75.73

2.17%

$80.94

0.02%